Abbott (Formerly Known as Alere INC.)
Alere manufactures innovative point of care health care diagnostics
Based in MA
🤖
AI Overview
With $2.7M in lobbying spend across 34 quarterly filings, Abbott (Formerly Known as Alere INC.) is a significant lobbying presence. They deploy 12 individual lobbyists Their lobbying covers 6 issue areas. Active from 2018 to 2025.
$2.7M
Total Spend
8
Years Active
1
Firms Hired
12
Lobbyists Deployed
6
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $320K |
| 2019 | $320K |
| 2020 | $320K |
| 2021 | $400K |
| 2022 | $400K |
| 2023 | $320K |
| 2024 | $320K |
| 2025 | $320K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Taxation, Medicare/Medicaid, Budget/Appropriations, Trade and 1 more
- •medical device user fee reauthorization, diagnostics regulation, in vitro diagnostics, influenza preparedness, opioids
- •PL 114-255 - 21st Century Cures, implementation
- •H.R. 2430 - FDA Reauthorization A
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 22,000% ROI
When lobbying spending yields outsized returns.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.